Jue Wang

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. pmc Metastases from nested variant urothelial carcinoma of the urinary bladder in pancreatic allograft mimicking graft rejection
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    J Clin Med Res 4:145-8. 2012
  2. pmc The natural history and outcomes of the patients with carcinosarcoma involving kidney and renal pelvis
    Jue Wang
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Adv Urol 2011:693964. 2011
  3. pmc Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Int J Surg Oncol 2010:381795. 2010
  4. pmc Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Prostate Cancer 2011:216169. 2011
  5. pmc Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases
    Jue Wang
    Section of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Sarcoma 2010:. 2010
  6. pmc Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis
    Jue Wang
    Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebr, USA
    Case Rep Oncol 5:9-16. 2012
  7. pmc Calcaneal acrometastasis from urothelial carcinoma of the ureter: a case report and literature review
    Jonathan H Ryder
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Interv Aging 8:395-9. 2013
  8. pmc Teratoma with malignant transformation: a case report with pathological, cytogenetic, and immunohistochemistry analysis
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Sarcoma 2011:450743. 2011
  9. pmc Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Rare Tumors 2:e47. 2010
  10. pmc Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate
    Jue Wang
    Department of Internal Medicine, Oncology Hematology Division, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Clin Interv Aging 8:871-7. 2013

Collaborators

Detail Information

Publications18

  1. pmc Metastases from nested variant urothelial carcinoma of the urinary bladder in pancreatic allograft mimicking graft rejection
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    J Clin Med Res 4:145-8. 2012
    ..KEYWORDS: Bladder cancer; Nested variant of urothelial carcinoma; Pancreas and kidney transplantation...
  2. pmc The natural history and outcomes of the patients with carcinosarcoma involving kidney and renal pelvis
    Jue Wang
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Adv Urol 2011:693964. 2011
    ..Conclusion. CSKP commonly presented as high-grade, advanced stage disease, and was associated with a poor prognosis regardless of location...
  3. pmc Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Int J Surg Oncol 2010:381795. 2010
    ..Of greatest concern is that the patients who declined CDS had an impaired survival. This information might be helpful for patients to make a better-informed decision...
  4. pmc Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Prostate Cancer 2011:216169. 2011
    ..This information could be useful when counseling these patients and emphasizes the need for new strategies and molecular-based therapeutic approaches for younger patients with SRPC...
  5. pmc Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases
    Jue Wang
    Section of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Sarcoma 2010:. 2010
    ..Emphasis on early detection, including identification of risk factors is needed to improve the outcome for patients with this malignancy...
  6. pmc Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis
    Jue Wang
    Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebr, USA
    Case Rep Oncol 5:9-16. 2012
    ..We highlight the role of molecular profiling in the diagnosis and management of this patient and the implication of personalized chemotherapy in this challenging disease...
  7. pmc Calcaneal acrometastasis from urothelial carcinoma of the ureter: a case report and literature review
    Jonathan H Ryder
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Interv Aging 8:395-9. 2013
    ..Bone metastasis of ureteral cancer can occur in nearby bone structures, such as the spine, pelvis, and hip bone. Distal bone metastasis, such as that in the calcaneus bone, however, is rare...
  8. pmc Teratoma with malignant transformation: a case report with pathological, cytogenetic, and immunohistochemistry analysis
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Sarcoma 2011:450743. 2011
    ..Conclusion. The activity of topoisomerase inhibitors and the potential usefulness of topoisomerase expression as biomarkers should be further tested in aprospective study...
  9. pmc Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    Rare Tumors 2:e47. 2010
    ..Adenosquamous cell carcinoma is a rare aggressive subtype of prostate cancer with poor cancer specific survival. The development of new therapeutic approaches for this aggressive tumor is urgently needed...
  10. pmc Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate
    Jue Wang
    Department of Internal Medicine, Oncology Hematology Division, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Clin Interv Aging 8:871-7. 2013
    ..The effects of age on clinical presentation, treatment, and outcomes for patients with small-cell carcinoma of the prostate (SCCP) are unclear...
  11. doi The impact of signet-ring cell carcinoma histology on bladder cancer outcome
    Jue Wang
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    World J Urol 30:777-83. 2012
    ..Signet-ring cell carcinoma (SRCC) of the urinary bladder is a rare entity. No previous studies have directly compared the cancer-specific survival of patients with SRCC to patients with urothelial carcinoma (UC) of the urinary bladder...
  12. pmc Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell carcinoma
    Jue Wang
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    World J Surg Oncol 9:155. 2011
    ..Metastatic renal cell carcinoma (RCC) presents a therapeutic challenge for clinicians because of the unpredictable clinical course, resistance to chemotherapy or radiotherapy and the limited response to immunotherapy...
  13. doi Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder
    Jue Wang
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Urol Int 86:453-60. 2011
    ....
  14. ncbi Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Med Oncol 25:125-32. 2008
    ..Therefore it was managed by surgeons. However, with growing evidence of the benefit of adjuvant chemotherapy, such patients should also be evaluated by a medical oncologist...
  15. pmc Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer
    Jue Wang
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Cancer 112:382-90. 2008
    ..The authors assessed patterns of perioperative chemotherapy use in elderly patients with resected stage I, II, or IIIA nonsmall cell lung cancer (NSCLC) from 1992 to 2002...
  16. pmc Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells
    Yu Wei Chou
    Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198 5870, USA
    Cancer Lett 311:177-86. 2011
    ..Thus, cPAcP expression is involved in growth suppression by HDAC inhibitors in PCa cells, and VPA pre-treatments increase androgen responsiveness...
  17. ncbi The inhibition of lung cancer cell growth by intracellular immunization with LC-1 ScFv
    Liang Chen
    Laboratory of Cellular Immunology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
    Cell Res 12:47-54. 2002
    ....